Clinical Trials Logo
  1. Home
  2. THC
  3. NCT04130633

Behavioral Pharmacology of THC and Alpha-pinene

THC Clinical Trial

Official title:
Behavioral Pharmacology of THC and Alpha-pinene

Clinical Trial Summary

This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized alpha-pinene and THC administered via inhalation.

Clinical Trial Description

The proposed study will be conducted at the Johns Hopkins Behavioral Pharmacology Research Unit (BPRU). Participants will complete 9 acute drug administration periods in which they will administer THC alone, pinene alone, THC and pinene together, or placebo. Subjective drug effects, cognitive performance, and vital signs will be assessed following drug administration. Each participant will receive all 9 dose conditions in a randomized order using a placebo controlled within-subject crossover design. The study will help the investigators understand the individual and interactive effects of THC and pinene, two common constituents found in cannabis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04130633
Study type Interventional
Source Johns Hopkins University
Contact Ryan Vandrey, PhD
Phone 410-550-4036
Email rvandrey@jhmi.edu
Status Recruiting
Phase Phase 1
Start date November 5, 2020
Completion date June 30, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT04976738 - A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Phase 1/Phase 2
Not yet recruiting NCT06378957 - Behavioral Pharmacology of Orally Administered THC and D-limonene Phase 1
Active, not recruiting NCT03560934 - Tetrahydrocannabinol (THC) and Sleep Early Phase 1
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Recruiting NCT04429568 - THC Crossover Study N/A
Completed NCT05121506 - A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults Phase 1
Completed NCT04360044 - Efficacy of Inhaled Cannabis for Acute Migraine Treatment Phase 2
Withdrawn NCT04340700 - Characterization of the Pharmacodynamic Response to Vaped THC Phase 3
Not yet recruiting NCT06099379 - Modulation of THC Effects by CBD: a Dose-ranging Study Phase 1/Phase 2
Completed NCT04851392 - Do Adolescents and Adults Differ in Their Acute Response to Cannabis? N/A
Completed NCT04294966 - Age-Related Effects of THC Early Phase 1
Recruiting NCT05116527 - THC Memory & Reward Learning Pilot Phase 1/Phase 2
Recruiting NCT05514899 - Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV Phase 2
Not yet recruiting NCT03098940 - A Bioavailability Study on Dronabinol Phase 1
Active, not recruiting NCT02102113 - Probing the Cannabinoid System in Individuals With a Family History of Psychosis Early Phase 1
Not yet recruiting NCT06077292 - Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults N/A
Suspended NCT05427630 - Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment Phase 2
Not yet recruiting NCT05641766 - Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks Phase 2